NTRA Natera Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NTRA

Price (delayed)

$44.97

Market cap

$5.15B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.82

Enterprise value

$5.21B

Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a ...

Highlights
NTRA's revenue is up by 29% year-on-year and by 7% since the previous quarter
The EPS has increased by 21% YoY and by 10% from the previous quarter
NTRA's equity is up by 34% year-on-year but it is down by 8% since the previous quarter
The company's debt rose by 9% YoY
The gross margin has declined by 8% year-on-year
Sector: Healthcare
Industry: Diagnostics & Research
Peers: PTCT PRTA VRTX

Key stats

What are the main financial stats of NTRA
Market
Shares outstanding
114.6M
Market cap
$5.15B
Enterprise value
$5.21B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
8.62
Price to sales (P/S)
5.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.59
Earnings
Revenue
$931.05M
EBIT
-$499.99M
EBITDA
-$466.15M
Free cash flow
-$387.25M
Per share
EPS
-$4.82
Free cash flow per share
-$3.41
Book value per share
$5.22
Revenue per share
$8.19
TBVPS
$10.98
Balance sheet
Total assets
$1.25B
Total liabilities
$651.75M
Debt
$433.81M
Equity
$596.15M
Working capital
$788.66M
Liquidity
Debt to equity
0.73
Current ratio
3.85
Quick ratio
3.6
Net debt/EBITDA
-0.11
Margins
EBITDA margin
-50.1%
Gross margin
42.5%
Net margin
-55%
Operating margin
-54.9%
Efficiency
Return on assets
-41.2%
Return on equity
-88.5%
Return on invested capital
-47.2%
Return on capital employed
-51.5%
Return on sales
-53.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NTRA stock price

How has the Natera stock price performed over time
Intraday
-0.51%
1 week
-11%
1 month
-21.63%
1 year
5.69%
YTD
11.95%
QTD
-7.58%

Financial performance

How have Natera's revenue and profit performed over time
Revenue
$931.05M
Gross profit
$395.97M
Operating income
-$511.55M
Net income
-$511.79M
Gross margin
42.5%
Net margin
-55%
The company's net margin rose by 31% YoY and by 13% QoQ
NTRA's operating margin is up by 30% year-on-year and by 12% since the previous quarter
NTRA's revenue is up by 29% year-on-year and by 7% since the previous quarter
Natera's gross profit has increased by 18% YoY and by 8% QoQ

Growth

What is Natera's growth rate over time

Valuation

What is Natera stock price valuation
P/E
N/A
P/B
8.62
P/S
5.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.59
The EPS has increased by 21% YoY and by 10% from the previous quarter
The stock's P/B is 69% less than its 5-year quarterly average of 27.8 and 4.7% less than its last 4 quarters average of 9.1
NTRA's equity is up by 34% year-on-year but it is down by 8% since the previous quarter
NTRA's price to sales (P/S) is 44% lower than its 5-year quarterly average of 9.9 and 4.8% lower than its last 4 quarters average of 5.8
NTRA's revenue is up by 29% year-on-year and by 7% since the previous quarter

Efficiency

How efficient is Natera business performance
The ROS has increased by 31% YoY and by 13% from the previous quarter
The ROA is up by 15% year-on-year and by 10% since the previous quarter
The ROE has grown by 12% from the previous quarter and by 8% YoY
The return on invested capital has increased by 4.5% since the previous quarter but it has declined by 4% year-on-year

Dividends

What is NTRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NTRA.

Financial health

How did Natera financials performed over time
NTRA's total assets is 91% higher than its total liabilities
NTRA's total assets is up by 17% YoY but it is down by 5% QoQ
The current ratio is up by 8% year-on-year
The company's debt is 27% lower than its equity
NTRA's equity is up by 34% year-on-year but it is down by 8% since the previous quarter
The debt to equity has contracted by 18% YoY but it has grown by 9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.